LINICAL
White Papers
THE LATEST
November 18, 2026
Benefit-risk in early-phase trials: why PV must move from safety oversight to strategic decision partner
As uncertainty defines early-phase clinical development, how can proactive benefit-riskassessment and pharmacovigilance protect patients without...
SIGN UP FOR OUR NEWSLETTER
June 3, 2026
PharmaBoardroom Interview with Dr Toshiaki Nagafuji on the Japanese Clinical Development Landscape in 2026
"Mid-sized CROs like Linical can be suitable partners for relatively small pharmaceutical and biotech companies that are searching for flexibility...
ALL NEWS & EVENTS
September 26, 2024
Taking the Legwork out of Your Clinical Trials
March 15, 2024